
CTXR
Healthcare · Biotechnology · $14.7M market cap
$0.5351+0.00 (+0.5%)Nov 13, 4:00 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · -64.0% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Dec 22, 2026 · upcoming | Time not confirmed | -0.41 | — | — |
| Aug 14, 2026 | After the close | -0.36 | -0.34 | +5.6% |
| May 15, 2026 | After the close | -0.32 | -0.95 | -196.9% |
| Feb 13, 2026 | Time not confirmed | -0.30 | -0.38 | -26.7% |
| Dec 23, 2025 | After the close | -0.24 | -0.11 | +54.2% |
| Aug 12, 2025 | After the close | -0.21 | -0.80 | -281.0% |
| May 14, 2025 | After the close | 0.11 | -1.27 | -1254.5% |
| Feb 12, 2025 | Before the open | -1.25 | -1.30 | -4.0% |
| Dec 27, 2024 | After the close | -1.50 | -5.80 | -286.7% |
| Aug 12, 2024 | After the close | -1.12 | -1.50 | -33.9% |
| May 14, 2024 | After the close | -1.50 | -1.25 | +16.7% |
| Feb 14, 2024 | After the close | 0.13 | -0.06 | -146.2% |
| Dec 29, 2023 | After the close | -1.50 |
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a…
| -1.75 |
| -16.7% |
| Aug 14, 2023 | After the close | -1.75 | -1.50 | +14.3% |
| May 12, 2023 | After the close | -1.25 | -1.75 | -40.0% |
| Feb 10, 2023 | After the close | -0.06 | -0.02 | +66.7% |
| Dec 22, 2022 | After the close | -1.50 | -1.25 | +16.7% |
| Aug 11, 2022 | After the close | -1.50 | -1.50 | 0.0% |
| May 12, 2022 | After the close | -1.75 | -1.25 | +28.6% |
| Feb 10, 2022 | After the close | -1.50 | -1.50 | 0.0% |
| Dec 15, 2021 | After the close | -0.04 | -0.02 | +50.0% |
| Aug 12, 2021 | After the close | -1.00 | -1.25 | -25.0% |
| May 13, 2021 | Before the open | -2.25 | -1.00 | +55.6% |
| Feb 11, 2021 | After the close | 0.16 | -0.15 | -193.8% |
| Dec 16, 2020 | After the close | -2.50 | -1.75 | +30.0% |
| Aug 14, 2020 | After the close | -2.75 | -2.75 | 0.0% |
| May 14, 2020 | After the close | -2.75 | -3.25 | -18.2% |
| Feb 13, 2020 | After the close | -3.50 | -3.75 | -7.1% |
| Dec 16, 2019 | After the close | -0.14 | -0.16 | -14.3% |
| Aug 14, 2019 | After the close | -1.50 | -5.00 | -233.3% |
| May 15, 2019 | After the close | -5.00 | -5.00 | 0.0% |
| Feb 14, 2019 | After the close | -5.25 | -5.50 | -4.8% |
| Dec 11, 2018 | After the close | -0.16 | -0.16 | 0.0% |
| Aug 14, 2018 | After the close | -8.00 | -4.75 | +40.6% |
| May 11, 2018 | After the close | — | -0.44 | — |
| Mar 20, 2018 | Before the open | — | -0.38 | — |